AOK PLUS - DIE GESUNDHEITSKASSE FÜR SACHSEN UND THÜRINGEN has floated a tender for Contract notice: Pharmaceutical products. The project location is Germany and the tender is closing on 30 Nov 2019. The tender notice number is 413085-2018, while the TOT Ref Number is 27024669. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Germany

Summary : Contract notice: Pharmaceutical products

Deadline : 30 Nov 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 27024669

Document Ref. No. : 413085-2018

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AOK PLUS - DIE GESUNDHEITSKASSE FÜR SACHSEN UND THÜRINGEN
Office Name: AOK PLUS - die Gesundheitskasse für Sachsen und Thüringen
Address: Augustinerstraße 38
Town: Erfurt
Postal Code: 99084
Contact Point: Unternehmensbereich Corporate Governance, Geschäftsbereich Zentrale Vergabestelle
Attention: Herrn Rechtsanwalt Sören Rabe


Germany
Email :vergabestelle@plus.aok.de
URL :https://plus.aok.de

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: Not specified
CPV code: 33600000, 33600000
CPV Description: Conclusion of non-exclusive discount agreements according to - 130a Abs. 8 SGB V at any time within the scope of a so-called "open-house model" within the period from 16.10.2018 to 30.11.2019 for drugs to the drug combination beclometasone / formoterol (ATC code according to WHO: R03AK08)

Pharmaceutical products.

The subject of this publication is the conclusion of Discount AssociationConclusions pursuant to Section 130a (8) SGB V for medicinal products for the combination of beclometasone / formoterol (WHO code: R03AK08) within the framework of a so-called "open-house model" uniform access procedure the conclusion of a discount agreement according to - 130a Abs. 8 SGB V-offered. An exclusivity is not given. The purchase quantity is unknown at the time the agreement is concluded and depends in particular on the demand of insured persons, the development of the number of insured persons, the prescribing behavior of contracted doctors and the dispensing and stocking behavior of public pharmacies. The client does not guarantee minimum purchase quantities.

The AThe agreement may be concluded at any time and on the same terms. Individual contract negotiations are not carried out.

Interested pharmaceutical companies can request the participation documents (discount agreement and the form mentioned under III.2.1) via the e-mail address mentioned under I.1).

Agreements under this model will be made in the period from-Closed on 16.10.2018 until 30.11.2019. Interested parties must submit the completed and signed participation documents (self-declaration on the absence of exclusion criteria and discount agreement) for the first time by 15.10.2018, then by the 15th of each month at the office specified under I.1). It depends on the access at the AOK PLUS. Occurs the 15th of a month auf a Saturday, Sunday or national public holiday, the next working day will take the place of such a day. For later entries (after 15.10.2018 or 15th of each month), the submitted participation documents will be considered for the 15th of the following month.

Participation documents can be submitted for the first time until 15.10.2018.

The discount agreement will be included-Signing the AOK PLUS in place. The signing will take place until the end of the month in which the registration documents have been received by the AOK PLUS.

Organizationally, AOK PLUS will need approximately half a month to complete the notification of the discount agreement. The initial labeling of the discount drug in the pharmacy software takes place from the-second month following the deadline for the participation documents. This deadline may vary in the event of changes or new deadlines for the deadline declarations in the nationwide AOK contract reporting portal DatRabatt.

With all pharmaceutical companies that fulfill the conditions for participation and confirm this by signing the requested documents, wed a discount agreement has been concluded.

The contract will end no later than 31.10.2020, irrespective of the date of conclusion of the contract. AOK PLUS reserves the right to terminate the open-house procedure prematurely, especially in the case of the conclusion of exclusive discount agreements. In this case, the contracts already concluded shall terminate in accordance with the contractual provisions. The experienceUnder the AOK PLUS, exclusive rebate agreements will normally enter into force 8 to 12 months after the publication of the relevant call for tenders in the Supplement to the Official Journal of the European Union. The future contractors in the open-house model are invited to inform themselves regularly in the Supplement to the Official Journal of the European UnionWeis: this publication does not constitute the award of a public service contract within the meaning of the Public Procurement Directive (2014/24 / EU) or public procurement law. In order to ensure the widest possible degree of transparency for the intended conclusion of the contract, it is published in the Supplement to the Official Journal of the European Union. In the absence of a correspondingThe contract notice will be used in the publication form. The resulting conceptual requirements, such as the process name "open procedure", are solely due to the use of this announcement form and the publication platform.Another meaning, in particular a submission to procurement regulations, unless they are justifiedThis is not connected with this.

- Self-declaration on the absence of grounds for exclusion


Internet address (URL): https://plus.aok.de
Directive: Classical Directive (2004/18/EC)

Documents

 Tender Notice